<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>B. abyssinica</italic> has been used for the treatment of varieties of illnesses such as malaria, diarrhea, cholera, intestinal worms, amoebiasis, leprosy, diabetes, hypertension, febrile illness, and typhoid in Africa including Ethiopia.
 <xref rid="cit0017" ref-type="bibr">17</xref>â€“
 <xref rid="cit0021" ref-type="bibr">21</xref> The leaves of 
 <italic>Bersama abyssinica</italic> has been used for the treatment of diabetes mellitus in a different part of Ethiopian.
 <xref rid="cit0017" ref-type="bibr">17</xref>,
 <xref rid="cit0022" ref-type="bibr">22</xref> Significant in vitro alpha-amylase inhibition, free radical scavenging activities, and antidiabetic activity in single-dose diabetic mice, normoglycemic mice, and oral glucose loaded mice were reported in Ethiopia.
 <xref rid="cit0023" ref-type="bibr">23</xref> However, there is no previous study in the hypoglycemic, anti-hyperglycemic, and anti-hyperlipidemic effects of 
 <italic>Bersama Abyssinica Fresen</italic> (Melianthaceae) leaves solvent fractions in normoglycemic and streptozotocin-induced diabetic mice. Thus, this study aimed to evaluate the anti-diabetic, anti-hyperlipidemic activity, and effect on the bodyweight of the repeated doses of the solvent fractions of 
 <italic>Bersama abyssinica</italic> in normoglycemic and streptozotocin-induced diabetic mice.
</p>
